Hannah Dellabella

Most Recent Articles by Hannah Dellabella

Pegylated Interferon, Ribavirin May Improve LV Diastolic Dysfunction in Chronic Hepatitis C

Pegylated Interferon, Ribavirin May Improve LV Diastolic Dysfunction in Chronic Hepatitis C

By

HCV viral eradication resulted in improved left ventricular diastolic dysfunction.

High HCV Sustained Virologic Response Rates With Elbasvir/Grazoprevir in Real-World Setting

High HCV Sustained Virologic Response Rates With Elbasvir/Grazoprevir in Real-World Setting

By

Real-world effectiveness of elbasvir/grazoprevir for HCV GT1 or GT4 is similar in the US Veterans Affairs-treated population as compared with those reported in clinical trials.

CMS Physician Payment and Policy Changes Proposed for 2019

CMS Physician Payment and Policy Changes Proposed for 2019

By

CMS issued a proposal to update payment policies, quality provisions, and payment rates for services under the Medicare Physician Fee Schedule on or after January 1, 2019.

Sofosbuvir/Velpatasvir/Voxilaprevir Improves Outcomes After Prior DAA Regimen Failure

Sofosbuvir/Velpatasvir/Voxilaprevir Improves Outcomes After Prior DAA Regimen Failure

By

Treatment with sofosbuvir/velpatasvir/voxilaprevir led to improvements in patient-reported outcomes in patients who had previously not responded to another DAA regimen.

Non-Targeted, Opt-Out HCV Testing May Be Successfully Implemented in ED Settings

Non-Targeted, Opt-Out HCV Testing May Be Successfully Implemented in ED Settings

By

Non-targeted, opt-out testing for HCV infection can be successfully implemented in the ED setting.

More Articles by Hannah Dellabella

Sign Up for Free e-newsletters